Stocktoria
GILEAD SCIENCES, INC. GILD
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1992-01-22
GILEAD SCIENCES, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Dickinson Andrew D | Chief Financial Officer | 2026-06-15 | Sell | 3,000 | $125.40 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | 2026-06-15 | Sell | 450 | $125.40 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | 2026-06-15 | Sell | 1,480 | $123.42 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | 2026-06-15 | Sell | 1,070 | $124.00 |
| Berger Dietmar | Chief Medical Officer | 2026-06-10 | Tax withheld | 263 | $121.48 |
| Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | 2026-06-10 | Option exercise | 589 | — |
| Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | 2026-06-10 | Tax withheld | 283 | $121.48 |
| Berger Dietmar | Chief Medical Officer | 2026-06-10 | Option exercise | 533 | — |
Source: SEC EDGAR filings · CIK 0000882095 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.